Pyxis Oncology, Inc. financial data

Symbol
PYXS on Nasdaq
Location
Boston, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 03 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 618% % -21%
Debt-to-equity 37% % 44%
Return On Equity -102% % -182%
Return On Assets -74% % -159%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 62,264,215 shares 4.7%
Common Stock, Shares, Outstanding 62,149,664 shares 4.5%
Entity Public Float $182,900,000 USD 89%
Common Stock, Value, Issued $62,000 USD 5.1%
Weighted Average Number of Shares Outstanding, Basic 62,557,386 shares 3%
Weighted Average Number of Shares Outstanding, Diluted 62,557,386 shares 3%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $2,820,000 USD
Cost of Revenue $475,000 USD
Research and Development Expense $66,009,000 USD 17%
General and Administrative Expense $22,041,000 USD -17%
Operating Income (Loss) $106,194,000 USD -58%
Nonoperating Income (Expense) $7,227,000 USD -26%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $22,003,000 USD -3.8%
Income Tax Expense (Benefit) $283,000 USD
Net Income (Loss) Attributable to Parent $97,086,000 USD -69%
Earnings Per Share, Basic -1 USD/shares -56%
Earnings Per Share, Diluted -1 USD/shares -56%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $8,919,000 USD -26%
Marketable Securities, Current $67,337,000 USD -49%
Cash, Cash Equivalents, and Short-term Investments $76,300,000 USD -47%
Accounts Receivable, after Allowance for Credit Loss, Current $3,000,000 USD
Other Assets, Current $674,000 USD 107%
Assets, Current $83,073,000 USD -44%
Property, Plant and Equipment, Net $8,460,000 USD -19%
Operating Lease, Right-of-Use Asset $11,637,000 USD
Intangible Assets, Net (Excluding Goodwill) $2,434,000 USD -90%
Assets $105,604,000 USD -46%
Accounts Payable, Current $9,756,000 USD 100%
Employee-related Liabilities, Current $3,983,000 USD -24%
Accrued Liabilities, Current $7,996,000 USD -43%
Liabilities, Current $19,382,000 USD -4.6%
Deferred Income Tax Liabilities, Net $0 USD -100%
Operating Lease, Liability, Noncurrent $17,400,000 USD -8.6%
Liabilities $36,825,000 USD -12%
Accumulated Other Comprehensive Income (Loss), Net of Tax $69,000 USD -80%
Retained Earnings (Accumulated Deficit) $425,071,000 USD -30%
Stockholders' Equity Attributable to Parent $68,779,000 USD -55%
Liabilities and Equity $105,604,000 USD -46%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $22,535,000 USD -8.8%
Net Cash Provided by (Used in) Financing Activities $57,511,000 USD
Net Cash Provided by (Used in) Investing Activities $15,821,000 USD
Common Stock, Shares Authorized 190,000,000 shares 0%
Common Stock, Shares, Issued 62,149,664 shares 4.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $6,714,000 USD -137%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $10,391,000 USD -23%
Deferred Tax Assets, Valuation Allowance $140,461,000 USD 18%
Deferred Tax Assets, Gross $144,599,000 USD 14%
Operating Lease, Liability $20,100,000 USD -5.8%
Payments to Acquire Property, Plant, and Equipment $237,000 USD -95%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $97,368,000 USD -71%
Lessee, Operating Lease, Liability, to be Paid $29,085,000 USD -9.9%
Property, Plant and Equipment, Gross $15,132,000 USD -2.2%
Operating Lease, Liability, Current $1,630,000 USD 17%
Lessee, Operating Lease, Liability, to be Paid, Year Two $3,375,000 USD 3%
Lessee, Operating Lease, Liability, to be Paid, Year One $3,278,000 USD 2.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $8,985,000 USD -18%
Lessee, Operating Lease, Liability, to be Paid, Year Three $3,473,000 USD 2.9%
Deferred Tax Assets, Operating Loss Carryforwards $78,213,000 USD 16%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $2,003,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $3,575,000 USD 2.9%
Operating Lease, Payments $2,995,000 USD 0%
Additional Paid in Capital $493,719,000 USD 2.6%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $552,000 USD -51%
Deferred Tax Assets, Net of Valuation Allowance $4,138,000 USD -46%
Share-based Payment Arrangement, Expense $12,492,000 USD -6.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%